Your browser doesn't support javascript.
loading
Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion.
Kim, Eun Ky; Oh, Tae Jung; Kim, Lee-Kyung; Cho, Young Min.
  • Kim EK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Oh TJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Kim LK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Cho YM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
J Korean Med Sci ; 31(2): 222-30, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26839476
ABSTRACT
Dietary fiber improves hyperglycemia in patients with type 2 diabetes through its physicochemical properties and possible modulation of gut hormone secretion, such as glucagon-like peptide 1 (GLP-1). We assessed the effect of dietary fiber-enriched cereal flakes (DC) on postprandial hyperglycemia and gut hormone secretion in patients with type 2 diabetes. Thirteen participants ate isocaloric meals based on either DC or conventional cereal flakes (CC) in a crossover design. DC or CC was provided for dinner, night snack on day 1 and breakfast on day 2, followed by a high-fat lunch. On day 2, the levels of plasma glucose, GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and insulin were measured. Compared to CC, DC intake exhibited a lower post-breakfast 2-hours glucose level (198.5±12.8 vs. 245.9±15.2 mg/dL, P<0.05) and a lower incremental peak of glucose from baseline (101.8±9.1 vs. 140.3±14.3 mg/dL, P<0.001). The incremental area under the curve (iAUC) of glucose after breakfast was lower with DC than with CC (P<0.001). However, there were no differences in the plasma insulin, glucagon, GLP-1, and GIP levels. In conclusion, acute administration of DC attenuates postprandial hyperglycemia without any significant change in the representative glucose-regulating hormones in patients with type 2 diabetes (ClinicalTrials.gov. NCT 01997281).
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucemia / Fibras de la Dieta / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucemia / Fibras de la Dieta / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article